{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:15:35Z","timestamp":1778577335299,"version":"3.51.4"},"reference-count":15,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccination remains one of the most effective public health interventions for preventing infectious diseases, reducing morbidity, mortality, and healthcare burden worldwide [...]<\/jats:p>","DOI":"10.3390\/vaccines14050426","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:49:09Z","timestamp":1778572149000},"page":"426","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccination in Immune-Mediated Intestinal Diseases: Efficacy, Safety, and Future Directions"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-7280","authenticated-orcid":false,"given":"Adi","family":"Lahat","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Samson Assuta Ashdod Medical Center, Faculty of Medicine, Ben Gurion University of the Negev, Be\u2019er Sheva 7747629, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-3313","authenticated-orcid":false,"given":"Kassem","family":"Sharif","sequence":"additional","affiliation":[{"name":"Advanced Endoscopy Unit, Beth Israel Deaconess Medical Centre, Faculty of Medicine, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with Inflammatory Bowel Disease Are at Risk for Vaccine-Preventable Illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease","volume":"112","author":"Melmed","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: Recommendations from an international consensus meeting","volume":"70","author":"Melmed","year":"2021","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: Deficiencies in gastroenterologists knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2011","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ibd\/izx001","article-title":"Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients with Inflam-matory Bowel Disease on Infliximab Therapy","volume":"24","author":"Pratt","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","article-title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.14309\/ajg.0000000000001342","article-title":"Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease","volume":"116","author":"Botwin","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S2468-1253(22)00274-6","article-title":"COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): A multicentre, prospective, case-control study","volume":"7","author":"Alexander","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Vollenberg, R., Lorentzen, E.U., K\u00fchn, J., Nowacki, T.M., Meier, J.A., Trebicka, J., and Tepasse, P.-R. (2023). Humoral Immunity in Immunosuppressed IBD Patients After the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects. Vaccines, 11.","DOI":"10.3390\/vaccines11091411"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Woelfel, S., D\u00fctschler, J., Junker, D., K\u00f6nig, M., Leinenkugel, G., Graf, N., Krieger, C., Truniger, S., Franke, A., and Koller, S. (2024). Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease. Vaccines, 12.","DOI":"10.3390\/vaccines12070774"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Woelfel, S., D\u00fctschler, J., Junker, D., K\u00f6nig, M., Leinenkugel, G., Krieger, C., Truniger, S., Franke, A., Koller, S., and Metzger-Peter, K. (2025). XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease. Vaccines, 13.","DOI":"10.3390\/vaccines13070759"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Scarmozzino, R., Zanoni, G., Arcolaci, A., and Ciccocioppo, R. (2024). Vaccine Efficacy and Safety in Patients with Celiac Disease. Vaccines, 12.","DOI":"10.3390\/vaccines12121328"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alexeeva, E., Dvoryakovskaya, T., Fetisova, A., Kriulin, I., Krekhova, E., Kabanova, A., Labinov, V., Labinova, E., and Kostik, M. (2025). The Efficacy and Safety of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus influenzae Type b Infections in Children with Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study. Vaccines, 13.","DOI":"10.3390\/vaccines13020177"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/426\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:46:32Z","timestamp":1778575592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["vaccines14050426"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14050426","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}